A Thrifty Variant in CREBRF Strongly Influences Body Mass Index in Samoans
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
An Example of the CREBRF Locus
bioRxiv preprint doi: https://doi.org/10.1101/789073; this version posted October 1, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Population specific reference panels are crucial for the genetic analyses of Native Hawai’ians: an example of the CREBRF locus Meng Lin1,†, Christian Caberto2, Peggy Wan1, Yuqing Li3, Annette Lum-Jones2, Maarit Tiirikainen2, Loreall Pooler1, Brooke Nakamura1, Xin Sheng1, Jacqueline Porcel1, Unhee Lim2, Veronica Wendy Setiawan1, Loïc Le Marchand2, Lynne R. Wilkens2, Christopher A. Haiman1, Iona Cheng3, Charleston W. K. Chiang1,4,† 1Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 2Epidemiology Program, University of Hawai’i Cancer Center, University of Hawai’i at Mānoa, Honolulu, Hawai’i 3Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California 4Quantitative Computational Biology Section, Department of Biological Sciences, University of Southern California, Los Angeles, California †Correspondence: [email protected], [email protected] Abstract Statistical imputation applied to genome-wide array data is the most cost-effective approach to complete the catalog of genetic variation in a study population. However, imputed genotypes in underrepresented populations incur greater inaccuracies due to ascertainment bias and a lack of representation among reference individuals,, further contributing to the obstacles to study these populations. Here we examined the consequences due to the lack of representation by genotyping a functionally important, Polynesian-specific variant, rs373863828, in the CREBRF gene, in a large number of self-reported Native Hawai’ians (N=3,693) from the Multiethnic Cohort. -
Targeting Cancer Cell Metabolism with Mitochondria- Immobilized Phosphorescent Cyclometalated Iridium(III) Complexes
Electronic Supplementary Material (ESI) for Chemical Science. This journal is © The Royal Society of Chemistry 2016 Electronic Supplementary Information Targeting cancer cell metabolism with mitochondria- immobilized phosphorescent cyclometalated iridium(III) complexes Jian-Jun Cao,a Cai-Ping Tan,*a Mu-He Chen,a Na Wu,a De-Yang Yao,b Xing-Guo Liu,b Liang-Nian Jia and Zong-Wan Mao*a a MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry and Chemical Engineering, Sun Yat-Sen University, Guangzhou 510275 (P. R. China). E-mail: [email protected]; [email protected] b Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People's Republic of China. S1 Table of Contents Experimental section Materials and measurements…………..........………………………..…………..…..………..……..S5 Synthesis and characterization…………..........………………………..……………..…….………..S5 Crystallographic structure determination…………..........………………………..…….……………S7 Stability studies of complex 2…………..........………………………..……………………..………S7 Cell lines and culture conditions…………..........………………………..……………..……………S8 Cytotoxicity assay…………..........………………………..……………..…………………………..S8 Co-culture of A549 cells and LO2 cells…………..........………………………..…….…………….S8 Lipophilicity…………..........………………………..……………..……………………………...…S8 ICP-MS measurement …………..........………………………..……………..……………………...S9 -
Qualifying Exam Study Guide and Examples
Department of Human Genetics PhD Qualifying Exam & MS Comprehensive Exam Preparation Materials Updated August 31, 2019 The doctoral Qualifying Exam and Master’s Comprehensive Exam begins with an oral presentation by the student of a research article from the primary literature. The paper serves as a starting point for an oral examination of the student’s understanding of the paper and knowledge of the field. Students will be required to demonstrate expertise in their chosen areas of concentration, which may include deeper knowledge than covered in the required coursework. In addition to mastery in their specific area, students will be required to demonstrate broad knowledge of the field of Human Genetics as a whole. Students will be responsible for showcasing their ability to utilize knowledge and skills obtained through coursework and research experiences to inform their interpretation, synthesis, and evaluation of the contemporary peer-reviewed literature. The following list of knowledge requirements that students are expected to master may be used to assist in preparing for the qualifying exam. Likewise, course objectives for the core Human Genetics curriculum are provided below and may serve as an outline of topics to assist in students’ preparations. Material covered in additional courses relevant to an individual student’s academic experience and trajectory may also be germane. Lastly, example qualifying exam questions pertaining to specific example papers are provided. Please be aware that some questions raised during the oral examination may not have clear or objective “right” answers, but may instead reflect current uncertainties in the field of human genetics. In these cases, students may be expected to provide thoughtful discussion regarding prevailing hypotheses or themes, demonstrate knowledge of ambiguities in the scientific evidence or limitations of our current knowledge, and propose new experiments that could yield insight into the question at hand. -
RNA Sequencing Unravels the Genetics of Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia SUPPLEMENTARY APPENDIX RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications Valentina Gianfelici, 1* Sabina Chiaretti, 1* Sofie Demeyer, 2,3 * Filomena Di Giacomo, 1,4 Monica Messina, 1 Roberta La Starza, 5 Nadia Peragine, 1 Francesca Paoloni, 6 Ellen Geerdens, 2,3 Valentina Pierini, 5 Loredana Elia, 1 Marco Mancini, 1 Maria Stefania De Propris, 1 Valerio Apicella, 1 Gianluca Gaidano, 7 Anna Maria Testi, 1 Antonella Vitale, 1 Marco Vignetti, 1,6 Cristina Mecucci, 5 Anna Guarini, 1 Jan Cools, 2,3 and Robin Foà 1 1Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy; 2Center for Human Genetics, KU Leuven, Belgium; 3Center for the Biology of Disease, VIB, Leuven, Belgium; 4Department of Molecular Biotechnology and Health Science and Center for Experimental Research and Medical Studies (CeRMS), University of Turin, Italy; 5Hematology and Bone Marrow Transplantation Unit, Department of Medicine, University of Perugia, Italy; 6GIMEMA Data Center, Rome, Italy; and 7Division of Hematol - ogy, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy * VG, SC and SD contributed equally to this work. ©2016 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol. 2015.139410 Received: November 12, 2015. Accepted: April 29, 2016. Pre-published: May 5, 2016. [email protected] SUPPLEMENTAL MATERIALS AND METHODS FISH analysis FISH was performed as previously described1 using probes selected from the genomic databases “NCBI” (National Center for Biotechnology Information, Annotation Release 106 and previous assembly) and “UCSC” (University of California, Santa Cruz, Genome Browser Feb.